New Achievement
-
- COVID-19
Sep 28, 2026Collaboration with Shionogi for drug discovery –Shionogi & Co., Ltd. European Commission Approval of Ensitrelvir Fumaric Acid (Xocova®) for Post-Exposure Prophylaxis of COVID-19 -
- COVID-19
Jun 19, 2026Collaboration with Shionogi for drug discovery –Shionogi & Co., Ltd. Xocova® Receives Expanded Approval in Japan for Pediatric Use -
- Highly pathogenic avian influenza virus (HPAIV)
Jun 04, 2026Evaluation of the Efficacy of Low-Concentration Gaseous Chlorine Dioxide in Inactivating Airborne H5 High Pathogenicity Avian Influenza Virus in Vivo Model